CUIMC/Herbert Irving Pavilion
161 Fort Washington Avenue
New York, NY 10032
New Patients
Existing Patients
Have you seen this provider?
Get Directionsto 161 Fort Washington Avenue (opens in new tab)
Insurances Accepted
Before your appointment, please contact the doctor's office or your insurance provider to verify that your insurance is accepted. This list of insurances can change, and the insurance plans listed may not be accepted at all office locations for this provider.
- Aetna Signature Administrators
- Medicare Managed Care
- HMO
- PPO
- POS
- EPO
- NY Signature
- Student Health
- Essential Plan
- Medicaid Managed Care
- Special Needs
- Medicare Managed Care
- PPO
- HMO
- Great West (National)
- EPO
- POS
- PPO
- Medicare Managed Care
- Select Care (Exchange)
- Vytra
- EPO
- Medicare Managed Care
- HMO
- PPO
- POS
- ConnectiCare
- Essential Plan
- Medicaid Managed Care
- Medicaid Managed Care
- Child/Family Health Plus
- Essential Plan
- PPO
- Medicare Managed Care
- HMO
- EPO
- Essential Plan
- Medicaid Managed Care
- Medicare Managed Care
- Child/Family Health Plus
- Leaf (Exchange)
- Medicaid Managed Care
- Child/Family Health Plus
- Medicare Managed Care
- Medicare Managed Care
- Local 1199
- MagnaCare
- Traditional Medicare
- Railroad
- Multiplan
- HMO
- Essential Plan
- Child/Family Health Plus
- Medicaid Managed Care
- Special Needs
- HMO
- POS
- PPO
- Empire Plan
- Compass (Exchange)
- Oxford Liberty
- Oxford Freedom
- Oxford HMO
- Medicare Managed Care
- Medicaid (Community Plan)
- SelectHealth
- Medicare Managed Care
- Special Needs
- Medicaid Managed Care
- Medicare Managed Care
- World Trade Center Health Plan
About Mariam El-Ashmawy, MD, PhD
Mariam El-Ashmawy, MD PhD is a medical oncologist andtranslational scientist with specialization in the treatment of advanced skincancer and ocular melanoma. Her research investigates the complex geneticlandscape of cancer in order to develop new therapies.
In the laboratory, her work has been dedicated to understanding the complex genomic landscape of cancer and developing novel targeted therapeutic strategies. Her ongoing projects include testing novel RAS pathway inhibitors in preclinical models of gastric and esophageal cancer as well as a first-in-human clinical trials for patients with NRAS mutant melanoma.
LEADERSHIP, TITLES & POSITIONS
- Assistant Professor of Medicine
HOSPITAL AFFILIATIONS
- NewYork-Presbyterian / Columbia University Irving Medical Center
